Ipsen Sa Adr (OTCMKTS:IPSEY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday.
According to Zacks, “Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France. “
Shares of Ipsen Sa Adr (OTCMKTS:IPSEY) traded up 3.81% during midday trading on Friday, reaching $33.61. 2,705 shares of the company were exchanged. The company has a market capitalization of $11.08 billion and a P/E ratio of 44.24. Ipsen Sa Adr has a 52-week low of $14.15 and a 52-week high of $33.81. The stock has a 50-day moving average price of $30.89 and a 200 day moving average price of $23.63.
Receive News & Ratings for Ipsen Sa Adr Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ipsen Sa Adr and related companies with MarketBeat.com's FREE daily email newsletter.